Tetra Bio Pharma Inc (TBPMQ)

[Billydakidd]

Montreal-based Tetra Bio-Pharma, (TSXV: TBP) (OTCQB: TBPMF) has just received Health Canada approval for the phase 3 clinical trial of a smokable dried cannabis prescription drug. The drug, now known as PPP001, targets chronic pain, as well as pain associated with advanced cancer.

The clinical testing is designed to prove the safety and efficacy of medical cannabis and specifically of PPP001. Tetra Bio-Pharma CEO Bernard Fortier describes it like this: “It will be a landmark trial. It will be a landmark approval. It will be the first smokable cannabis drug that will be approved, as a legitimate drug, to be prescribed by physicians.”

Tetra has a strong development pipeline featuring drugs that treat chronic pain, nausea, insomnia, PTSD, and eye ailments. As CEO Bernard Fortier says, “We are not a one molecule company.”

Continued in link below...


http://momentumpr.com/sun-life-signals-start-mass-medical-cannabis-market/